by the prolific periosteal lesions sometimes seen in the ischaemic and neuropathic feet of patients with diabetes mellitus, and in the bone disorders associated with hyperparathyroidism, chronic renal failure, Gaucher's disease and vitamin A intoxication. In scurvy, periosteal osteoblasts fail to lay down normal bone matrix but proliferate themselves, producing a layer of cells separating the periosteum from the cortex which is followed by the typical subperiosteal haemorrhages seen in this deficiency disorder.
Hypertrophic osteoarthropathy is the most well known example of periostitis seen in association with neoplastic disorders (especially bronchogenic carcinoma) and occasionally in certain chronic pulmonary, cardiovascular, gastrointestinal and hepatic disorders. Here the pain of periostitis may be supplemented by that of adjacent synovitis, often seen in the wrists and ankles. Radiologically a thin line of new bone at the ends of the diaphysis thickens and eventually fuses with the cortex; as in secondary syphilis, these changes can be well documented using radionuclide scanningwhich may also indicate the presence of synovitis (Rosenthall & Kirsh 1976) -and here again it would seem that bone scans should be routine when hypertrophic osteoarthropathy is suspected.
Periostitis may occur in various types of inflammatory polyarthritis. As an important early diagnostic sign of rheumatoid disease, a fine periosteal reaction is visible along the metacarpals and phalanges of hands and feet, though the changes can be easily missed by the unpractised eye as they are delicate and subtle. A more florid type of periosteal reaction occurs in the seronegative spondarthritis group of arthritic disorders, such as Reiter's disease and psoriatic arthritis, where calcaneal periostitis and 'compound spur' formation give rise to severe pain in the heel, with later marked thickening of the cortex of the heel-bone. Such gross, 'fluffy' periostitis in a patient with sacroiliitis is more likely to indicate Reiter's disease or psoriatic arthritis than ankylosing spondylitis as the underlying disorder.
Various disorders of the vascular system where periostitis can be a feature include sickle-cell disease and certain types of polyarteritis. The condition may be responsible for pain and swelling of the small bones of the hands and feet in some patients with sickle-cell disease (Middlemiss & Raper 1966) . In localized, benign varieties of polyarteritis, where vascular lesions appear to be confined to the muscles of the lower limbs, occasionally painful and tender lumps appear on the shins due to focal areas of periostitis (Ball & Grayzell 1964) . In a recent case we found these swellings to be composed of an outer zone of dense collagenous tissue and an inner zone of mature scars of woven bone which, however, failed to show organization into a cortical table: comparison with the radiographic appearances showed that new bone formed within the fibrous periosteum, this resulting from ischaemia brought about by adjacent vasculitis. A relatively higher dose of systemic steroids was required to control the pain of such lesions. A similar condition was recently reported by Short & Webley (1984) in a boy with multisystemic polyarteritis, who developed nodular periostitic lesions on the limbs and was treated effectively by a pulsed infusion of methyl prednisolone. D N Golding Editorial Representative Section Long-term sequelae of whooping cough1
At one time, whooping cough was one of the commonest causes of death in children, with 7200 deaths in England alone in 1909 (Osler 1918) , but in 1972 only two children died in England and Wales (DHSS 1977) . Understandably, there was a good deal of complacency following this improvement, not only amongst parents but also amongst doctors. Some younger doctors had never seen whooping cough, while others not sufficiently familiar with the disease sometimes failed to recognize it when it occurred.
Following considerable adverse publicity about pertussis vaccine in the press and on television in 1974, the acceptance rate for the vaccine dropped dramatically to 37% in England and Wales and even lower in West Glamorgan to 9.5% (Swansea Research Unit RCGP 1981). Since pertussis vaccination was introduced on a national scale in 1Arising from presentation to Section of Epidemiology & Community Medicine, 14 March 1985 1957, the three or four yearly peaks, characteristic of whooping cough, had become successively smaller -the smallest being in 1974, the year the adverse publicity began. The sudden drop in vaccination rate after 1974 was followed in 1977 by the biggest epidemic for 20 years. Had the vaccine been ineffective, a peak of this magnitude would not have occurred and the downward trend would have resulted in a smaller peak than in 1974.
Possible serious risks from the vaccine were studied in the Childhood Encephalopathy Study (Alderslade et al. 1981 ) from which it was concluded that the risk of permanent brain damage was very small, 1 in 310 000 injections. It was also very important to see if there were still risks from the disease itself, especially as it occurs today, with the added benefits of antibiotics which have an effect on secondary infection rather than on the causative organism, Bordetella pertussis. For this purpose the 1977/79 epidemic was studied in detail in West Glamorgan (Swansea Research Unit RCGP 1981). Of the 2295 cases entered into the study, 1500 were under five years of age at onset of whooping cough, and 3 died-but not from pneumonia, a common cause of death before the introduction of antibiotics. Were there any longterm respiratory sequelae in these children? In a further study carried out in West Glamorgan 4years later to see if the disease had any long-term respiratory effects, 813 whooping cough children were compared with a control group of the same size who had not had whooping cough, each matched by age and sex with a child in the same class in school (Swansea Research Unit RCGP 1985) .
While there was no difference between the index (whooping cough) and control group in the number admitted to hospital for either upper or lower respiratory conditions before the onset of whooping cough, there was a significant excess of indexes admitted for the same condition after recovery from whooping cough. Some of the results from this study agree with a similar study carried out in London (Johnson et al. 1983 ) that residual respiratory symptoms were more common amongst the whooping cough children than controls. However, the two studies differ in that the London study found no difference in lung function between the two groups, whereas in West Glamorgan there was a poorer lung function in the index group, ages 4-7 inclusive, but no difference in the older groups 8 and 9. The children in the younger age groups would have been less than 34 years at onset of whooping cough, and, as the severity of whooping cough was found to have an inverse correlation with age, this would partly explain the poorer lung function in these younger children. It is also interesting that the 160 children who had respiratory complications (apnoea, pneumonia, atelectasis, asthma and haemoptosis) at the time of whooping cough, showed reasonably normal lung function test results * years later. This emphasizes the importance of spotting these complications when they occur in order to prevent possible long-term respiratory sequelae.
Another important difference between the London and West Glamorgan studies was that 41% of the children in the former had been treated in hospital compared with only 2.8% in West Glamorgan, all the rest being treated at home. Atelectasis is reported as being a very common complication of whooping cough (Lees 1950 , Forsyth et al. 1984 . Areas of atelectasis may go unnoticed in patients treated at home because of difficulty in the clinical detection of small areas of pulmonary collapse. It is possible that some children in West Glamorgan may have had such areas of atelectasis which had failed to expand, giving a permanently poorer lung function.
The West Glamorgan study also found a highly significant (P<0.001) excess of children with asthma in the whooping cough group (85: 10.5%) compared with the controls (54: 6.2%). It is known that live or killed Bordetalla pertussis, when injected into rats or mice, causes fl2adrenergic blockade affecting the smooth muscles of the bronchioles, making it more difficult for these animals to breathe; it may well be that this also occurs in children with whooping cough. Seventeen children developed asthma for the first time in the 1977/79 West Glamorgan epidemic, which may have been a chance occurrence. Of greater interest, however, is the finding that of those children with asthma, only 3.5% of whooping cough children compared with 30% ofcontrols had been fully vaccinated against pertussis. Whilst the guidelines on pertussis vaccination (DHSS 1984) mention that allergy is not a contraindication, no specific reference is made to asthma. There may be many doctors who consider a personal or family history of asthma to be a contraindication to pertussis vaccination. It is understandable that doctors may be 'playing safe' -'better be sure than sorry'-especially with the greater threat these days of medical litigation. It would be valuable to know if a child with a personal or family history of asthma is at no greater risk from the vaccine than any other normal child. Likewise, it would be important to know if the effects of whooping cough in a child with such a history are likely to be worse than in any other child. Answers to these questions would give doctors more confidence in deciding what is best for their patients.
There is no doubt that the greater risk from whooping cough is at the time of the illness, and it is not generally realised how serious this can be. There would probably be more deaths from whooping cough were it not for the diligence of parents, getting up night after night often for several weeks and being present if their child has a convulsion, an apnoeic attack or one of the frequent attacks of vomiting, so common in whooping cough, with the added risk of inhalation. W 0 Williams Director, Swansea Research Unit ofthe Royal College of General Practitioners
